G

Genedrive PLC
LSE:GDR

Watchlist Manager
Genedrive PLC
LSE:GDR
Watchlist
Price: 2.4 GBX -2.04% Market Closed
Market Cap: 13m GBX
Have any thoughts about
Genedrive PLC?
Write Note

Genedrive PLC
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genedrive PLC
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
G
Genedrive PLC
LSE:GDR
Total Liabilities
ÂŁ1.9m
CAGR 3-Years
9%
CAGR 5-Years
-28%
CAGR 10-Years
3%
Oxford Nanopore Technologies PLC
LSE:ONT
Total Liabilities
ÂŁ133.2m
CAGR 3-Years
12%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Total Liabilities
ÂŁ3.7m
CAGR 3-Years
5%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Ergomed PLC
LSE:ERGO
Total Liabilities
ÂŁ42.5m
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Total Liabilities
ÂŁ1.6m
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Total Liabilities
ÂŁ49.3m
CAGR 3-Years
36%
CAGR 5-Years
44%
CAGR 10-Years
44%
No Stocks Found

Genedrive PLC
Glance View

Market Cap
13m GBX
Industry
Life Sciences Tools & Services

Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. The Company’s Genedrive device is a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company’s commercial products include Genedrive MT-RNR1, Genedrive BioPlex, Genedrive HCV ID Kit and Genedrive 96 SARS-CoV-2 Ki. Genedrive MT-RNR1 is a commercial test for antibiotic induced hearing loss. Genedrive BioPlex is developed for the determination of military biothreats from pathogens. Genedrive HCV ID Kit is effective in the diagnosis of Hepatitis C Virus (HCV) infection in resource limited settings. Genedrive 96 SARS-CoV-2 Ki is a plate format of a COVID-19 molecular test for high throughput use, which detects all known variants of COVID-19.

GDR Intrinsic Value
0.41 GBX
Overvaluation 83%
Intrinsic Value
Price
G

See Also

What is Genedrive PLC's Total Liabilities?
Total Liabilities
1.9m GBP

Based on the financial report for Dec 31, 2023, Genedrive PLC's Total Liabilities amounts to 1.9m GBP.

What is Genedrive PLC's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
3%

Over the last year, the Total Liabilities growth was 40%. The average annual Total Liabilities growth rates for Genedrive PLC have been 9% over the past three years , -28% over the past five years , and 3% over the past ten years .

Back to Top